KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoodRx Holdings (GDRX) Interest & Investment Income (2019 - 2025)

GoodRx Holdings' Interest & Investment Income history spans 7 years, with the latest figure at $1.9 million for Q4 2025.

  • For Q4 2025, Interest & Investment Income fell 58.82% year-over-year to $1.9 million; the TTM value through Dec 2025 reached $10.9 million, down 53.02%, while the annual FY2025 figure was $10.9 million, 53.02% down from the prior year.
  • Interest & Investment Income for Q4 2025 was $1.9 million at GoodRx Holdings, down from $2.3 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $8.6 million in Q3 2023 and bottomed at $13000.0 in Q2 2021.
  • The 5-year median for Interest & Investment Income is $3.4 million (2022), against an average of $3.8 million.
  • The largest annual shift saw Interest & Investment Income crashed 78.67% in 2021 before it surged 31929.41% in 2022.
  • A 5-year view of Interest & Investment Income shows it stood at $17000.0 in 2021, then soared by 31929.41% to $5.4 million in 2022, then soared by 55.63% to $8.5 million in 2023, then tumbled by 45.87% to $4.6 million in 2024, then crashed by 58.82% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Interest & Investment Income are $1.9 million (Q4 2025), $2.3 million (Q3 2025), and $2.8 million (Q2 2025).